Endocrine Metabolic & Immune Disorders-Drug Targets

Papers
(The H4-Index of Endocrine Metabolic & Immune Disorders-Drug Targets is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Focus on Receptors for Coronaviruses with Special Reference to Angiotensin- Converting Enzyme 2 as a Potential Drug Target - A Perspective121
The Biochemical and Clinical Perspectives of Lactate Dehydrogenase: An Enzyme of Active Metabolism67
Are Oxidative Stress and Inflammation Mediators of Bone Loss Due to Estrogen Deficiency? A Review of Current Evidence48
MicroRNAs as Biomarker for Breast Cancer45
Rebalancing the Oral Microbiota as an Efficient Tool in Endocrine, Metabolic and Immune Disorders34
Natural Alkaloids and Diabetes Mellitus: A Review32
The Association of Metabolic Syndrome and Psoriasis: A Systematic Review and Meta-Analysis of Observational Study32
Role of Inflammation in the Development of Colorectal Cancer28
Quality of Life in Individuals with Diabetic Foot Syndrome27
Chronic Pancreatitis and the Development of Pancreatic Cancer27
A Review on the Role of Nanosensors in Detecting Cellular miRNA Expression in Colorectal Cancer25
Gender Dysphoria, Eating Disorders and Body Image: An Overview24
Hepatic Lipid Metabolism Disorder and Atherosclerosis24
Collagen Peptides, in Association with Vitamin C, Sodium Hyaluronate, Manganese and Copper, as Part of the Rehabilitation Project in the Treatment of Chronic Low Back Pain23
Diet: A Source of Endocrine Disruptors22
Molecular and Immunological Mechanisms Underlying the Various Pharmacological Properties of the Potent Bioflavonoid, Rutin21
Curcumin Nanomicelle Improves Lipid Profile, Stress Oxidative Factors and Inflammatory Markers in Patients Undergoing Coronary Elective Angioplasty; A Randomized Clinical Trial21
Phytotherapy of Hypertension: An Updated Overview20
Nickel Allergy: Epidemiology, Pathomechanism, Clinical Patterns, Treatment and Prevention Programs20
The Toxic Effects of Endocrine Disrupting Chemicals (EDCs) on Gut Microbiota: Bisphenol A (BPA) A Review20
0.037389039993286